<DOC>
	<DOCNO>NCT00803660</DOCNO>
	<brief_summary>Multi-centre survey type 2 diabetic patient currently anti-hypertensive treatment . Data collection patient take place one visit . To observe proportion diabetic patient antihypertensive treatment reach BP &lt; 130/80 mmHg . To observe proportion diabetic patient antihypertensive treatment reach BP &lt; 130/80 mmHg treatment group . To observe proportion patient achieve therapeutic glycemic response define HbA1c= &lt; 7 % . To observe proportion patient achieve fast plasma glucose &lt; 110 mg % . To identify factor achieve BP &lt; 130/80 mmHg . To describe percentage patient positive proteinuria ( include microalbuminuria ) treatment group .</brief_summary>
	<brief_title>Survey Treatment Hypertension Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Provision write informed consent Patient diagnose type 2 diabetes Patient antihypertensive treatment least 3 month , regimen minimum 4 week prior survey Patients critically ill , mental health problem difficulty communication Patients unwilling unable provide inform consent Involvement planning conduct study ( applies AstraZeneca staff staff study site ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>hypertension</keyword>
	<keyword>BP</keyword>
	<keyword>diabetes</keyword>
	<keyword>anti-hypertensive treatment</keyword>
	<keyword>ACE-I</keyword>
	<keyword>ARB</keyword>
</DOC>